Bengaluru-based biotechnology startup CrisprBits Private Limited has inaugurated a CRISPR gene editing and diagnostics laboratory in Bengaluru.
The new facility includes advanced infrastructure laboratory features with dedicated spaces for lyophilization (a process used to keep reagents stable at room temperature), cell and tissue culture, bacterial culture, molecular biology research, and cleanroom operations. Additionally, the laboratory includes a specialized gene editing section and a tissue culture area designed to support stem cell research. A state-of-the-art LIMS (Laboratory Information Management System) and intelligent systems for smart design of CRISPR guides round out the technology platforms at the CrisprBits innovation centre.
Commenting on the launch of the new facility, Dr Vijay Chandru, Co-founder & Director, CrisprBits, said, “The launch of our new facility in Bengaluru is a significant milestone in our journey to deliver affordable and high-quality solutions to enhance the health of people and the planet. The state-of-the-art CRISPR gene editing laboratory and diagnostics will better equip us to meet critical needs and develop solutions that have significant commercial and social impact.”
Incubated initially at the Center For Cellular and Molecular Platforms (CCAMP) for the past four years, CrisprBits has been focusing on developing a rapid point-of-need molecular diagnostics platform.
